ICD↔CPT crosswalk
CPT 0115U: ICD-10 codes that support medical necessity
These ICD-10-CM diagnoses support medical necessity for CPT 0115U under Medicare coverage policies (LCDs, NCDs, and Billing & Coding articles). Billing CPT 0115U with a diagnosis that isn't covered typically denies as CARC 50 — not medically necessary.
National approximation. Coverage varies by MAC and state — confirm against the specific LCD/NCD and article that applies to your jurisdiction and date of service.
| ICD-10 | Description |
|---|---|
| A00.0 | Cholera due to Vibrio cholerae 01, biovar cholerae |
| A00.1 | Cholera due to Vibrio cholerae 01, biovar eltor |
| A00.9 | Cholera, unspecified |
| A01.00 | Typhoid fever, unspecified |
| A01.01 | Typhoid meningitis |
| A01.02 | Typhoid fever with heart involvement |
| A01.03 | Typhoid pneumonia |
| A01.04 | Typhoid arthritis |
| A01.05 | Typhoid osteomyelitis |
| A01.09 | Typhoid fever with other complications |
| A01.1 | Paratyphoid fever A |
| A01.2 | Paratyphoid fever B |
| A01.3 | Paratyphoid fever C |
| A02.0 | Salmonella enteritis |
| A02.1 | Salmonella sepsis |
| A02.23 | Salmonella arthritis |
| A02.8 | Other specified salmonella infections |
| A03.0 | Shigellosis due to Shigella dysenteriae |
| A03.1 | Shigellosis due to Shigella flexneri |
| A03.2 | Shigellosis due to Shigella boydii |
| A03.3 | Shigellosis due to Shigella sonnei |
| A03.8 | Other shigellosis |
| A04.0 | Enteropathogenic Escherichia coli infection |
| A04.1 | Enterotoxigenic Escherichia coli infection |
| A04.2 | Enteroinvasive Escherichia coli infection |
| A04.3 | Enterohemorrhagic Escherichia coli infection |
| A04.5 | Campylobacter enteritis |
| A04.6 | Enteritis due to Yersinia enterocolitica |
| A04.71 | Enterocolitis due to Clostridium difficile, recurrent |
| A04.72 | Enterocolitis due to Clostridium difficile, not specified as recurrent |
| A04.8 | Other specified bacterial intestinal infections |
| A04.9 | Bacterial intestinal infection, unspecified |
| A05.0 | Foodborne staphylococcal intoxication |
| A05.1 | Botulism food poisoning |
| A05.2 | Foodborne Clostridium perfringens [Clostridium welchii] intoxication |
| A05.3 | Foodborne Vibrio parahaemolyticus intoxication |
| A05.4 | Foodborne Bacillus cereus intoxication |
| A05.5 | Foodborne Vibrio vulnificus intoxication |
| A06.0 | Acute amebic dysentery |
| A06.1 | Chronic intestinal amebiasis |
| A06.2 | Amebic nondysenteric colitis |
| A07.1 | Giardiasis [lambliasis] |
| A07.2 | Cryptosporidiosis |
| A07.4 | Cyclosporiasis |
| A08.0 | Rotaviral enteritis |
| A08.11 | Acute gastroenteropathy due to Norwalk agent |
| A08.19 | Acute gastroenteropathy due to other small round viruses |
| A08.2 | Adenoviral enteritis |
| A08.31 | Calicivirus enteritis |
| A08.32 | Astrovirus enteritis |
| A08.39 | Other viral enteritis |
| A08.8 | Other specified intestinal infections |
| A09 | Infectious gastroenteritis and colitis, unspecified |
| A32.11 | Listerial meningitis |
| A32.12 | Listerial meningoencephalitis |
| A32.7 | Listerial sepsis |
| A37.00 | Whooping cough due to Bordetella pertussis without pneumonia |
| A37.01 | Whooping cough due to Bordetella pertussis with pneumonia |
| A37.10 | Whooping cough due to Bordetella parapertussis without pneumonia |
| A37.11 | Whooping cough due to Bordetella parapertussis with pneumonia |
| A37.80 | Whooping cough due to other Bordetella species without pneumonia |
| A37.81 | Whooping cough due to other Bordetella species with pneumonia |
| A37.90 | Whooping cough, unspecified species without pneumonia |
| A37.91 | Whooping cough, unspecified species with pneumonia |
| A39.0 | Meningococcal meningitis |
| A39.81 | Meningococcal encephalitis |
| A39.9 | Meningococcal infection, unspecified |
| A40.0 | Sepsis due to streptococcus, group A |
| A40.1 | Sepsis due to streptococcus, group B |
| A40.3 | Sepsis due to Streptococcus pneumoniae |
| A40.8 | Other streptococcal sepsis |
| A40.9 | Streptococcal sepsis, unspecified |
| A41.01 | Sepsis due to Methicillin susceptible Staphylococcus aureus |
| A41.02 | Sepsis due to Methicillin resistant Staphylococcus aureus |
| A41.1 | Sepsis due to other specified staphylococcus |
| A41.2 | Sepsis due to unspecified staphylococcus |
| A41.3 | Sepsis due to Hemophilus influenzae |
| A41.4 | Sepsis due to anaerobes |
| A41.50 | Gram-negative sepsis, unspecified |
| A41.51 | Sepsis due to Escherichia coli [E. coli] |
| A41.52 | Sepsis due to Pseudomonas |
| A41.53 | Sepsis due to Serratia |
| A41.54 | Sepsis due to Acinetobacter baumannii |
| A41.59 | Other Gram-negative sepsis |
| A41.81 | Sepsis due to Enterococcus |
| A41.89 | Other specified sepsis |
| A41.9 | Sepsis, unspecified organism |
| A48.1 | Legionnaires' disease |
| A48.2 | Nonpneumonic Legionnaires' disease [Pontiac fever] |
| A51.0 | Primary genital syphilis |
| A51.1 | Primary anal syphilis |
| A51.31 | Condyloma latum |
| A52.76 | Other genitourinary symptomatic late syphilis |
| A54.00 | Gonococcal infection of lower genitourinary tract, unspecified |
| A54.01 | Gonococcal cystitis and urethritis, unspecified |
| A54.02 | Gonococcal vulvovaginitis, unspecified |
| A54.03 | Gonococcal cervicitis, unspecified |
| A54.09 | Other gonococcal infection of lower genitourinary tract |
| A54.1 | Gonococcal infection of lower genitourinary tract with periurethral and accessory gland abscess |
| A54.21 | Gonococcal infection of kidney and ureter |
| A54.22 | Gonococcal prostatitis |
| A54.23 | Gonococcal infection of other male genital organs |
| A54.24 | Gonococcal female pelvic inflammatory disease |
| A54.29 | Other gonococcal genitourinary infections |
| A54.42 | Gonococcal arthritis |
| A54.6 | Gonococcal infection of anus and rectum |
| A54.81 | Gonococcal meningitis |
| A54.86 | Gonococcal sepsis |
| A56.00 | Chlamydial infection of lower genitourinary tract, unspecified |
| A56.01 | Chlamydial cystitis and urethritis |
| A56.02 | Chlamydial vulvovaginitis |
| A56.09 | Other chlamydial infection of lower genitourinary tract |
| A56.11 | Chlamydial female pelvic inflammatory disease |
| A56.19 | Other chlamydial genitourinary infection |
| A56.2 | Chlamydial infection of genitourinary tract, unspecified |
| A56.3 | Chlamydial infection of anus and rectum |
| A59.00 | Urogenital trichomoniasis, unspecified |
| A59.01 | Trichomonal vulvovaginitis |
| A59.02 | Trichomonal prostatitis |
| A59.03 | Trichomonal cystitis and urethritis |
| A59.09 | Other urogenital trichomoniasis |
| A60.00 | Herpesviral infection of urogenital system, unspecified |
| A60.01 | Herpesviral infection of penis |
| A60.02 | Herpesviral infection of other male genital organs |
| A60.03 | Herpesviral cervicitis |
| A60.04 | Herpesviral vulvovaginitis |
| A60.09 | Herpesviral infection of other urogenital tract |
| A60.1 | Herpesviral infection of perianal skin and rectum |
| A60.9 | Anogenital herpesviral infection, unspecified |
| A63.0 | Anogenital (venereal) warts |
| A77.40 | Ehrlichiosis, unspecified |
| A77.41 | Ehrlichiosis chaffeensis [E. chaffeensis] |
| A77.49 | Other ehrlichiosis |
| A79.82 | Anaplasmosis [A. phagocytophilum] |
| A79.9 | Rickettsiosis, unspecified |
| A80.0 | Acute paralytic poliomyelitis, vaccine-associated |
| A80.1 | Acute paralytic poliomyelitis, wild virus, imported |
| A80.2 | Acute paralytic poliomyelitis, wild virus, indigenous |
| A80.30 | Acute paralytic poliomyelitis, unspecified |
| A80.39 | Other acute paralytic poliomyelitis |
| A80.4 | Acute nonparalytic poliomyelitis |
| A80.9 | Acute poliomyelitis, unspecified |
| A84.89 | Other tick-borne viral encephalitis |
| A84.9 | Tick-borne viral encephalitis, unspecified |
| A85.0 | Enteroviral encephalitis |
| A85.1 | Adenoviral encephalitis |
| A85.2 | Arthropod-borne viral encephalitis, unspecified |
| A85.8 | Other specified viral encephalitis |
| A86 | Unspecified viral encephalitis |
| A87.0 | Enteroviral meningitis |
| A87.8 | Other viral meningitis |
| A87.9 | Viral meningitis, unspecified |
| A93.8 | Other specified arthropod-borne viral fevers |
| A94 | Unspecified arthropod-borne viral fever |
| B00.0 | Eczema herpeticum |
| B00.1 | Herpesviral vesicular dermatitis |
| B00.2 | Herpesviral gingivostomatitis and pharyngotonsillitis |
| B00.3 | Herpesviral meningitis |
| B00.4 | Herpesviral encephalitis |
| B00.59 | Other herpesviral disease of eye |
| B01.0 | Varicella meningitis |
| B01.11 | Varicella encephalitis and encephalomyelitis |
| B01.81 | Varicella keratitis |
| B01.9 | Varicella without complication |
| B02.1 | Zoster meningitis |
| B02.30 | Zoster ocular disease, unspecified |
| B02.31 | Zoster conjunctivitis |
| B02.32 | Zoster iridocyclitis |
| B02.33 | Zoster keratitis |
| B02.34 | Zoster scleritis |
| B02.39 | Other herpes zoster eye disease |
| B02.7 | Disseminated zoster |
| B02.8 | Zoster with other complications |
| B10.01 | Human herpesvirus 6 encephalitis |
| B20 | Human immunodeficiency virus [HIV] disease |
| B25.0 | Cytomegaloviral pneumonitis |
| B25.1 | Cytomegaloviral hepatitis |
| B25.2 | Cytomegaloviral pancreatitis |
| B27.02 | Gammaherpesviral mononucleosis with meningitis |
| B27.12 | Cytomegaloviral mononucleosis with meningitis |
| B27.82 | Other infectious mononucleosis with meningitis |
| B33.23 | Viral pericarditis |
| B33.24 | Viral cardiomyopathy |
| B35.1 | Tinea unguium |
| B37.31 | Acute candidiasis of vulva and vagina |
| B37.32 | Chronic candidiasis of vulva and vagina |
| B37.41 | Candidal cystitis and urethritis |
| B37.42 | Candidal balanitis |
| B37.49 | Other urogenital candidiasis |
| B37.5 | Candidal meningitis |
| B37.7 | Candidal sepsis |
| B37.89 | Other sites of candidiasis |
| B45.1 | Cerebral cryptococcosis |
| B59 | Pneumocystosis |
| B60.00 | Babesiosis, unspecified |
| B60.01 | Babesiosis due to Babesia microti |
| B60.02 | Babesiosis due to Babesia duncani |
| B60.03 | Babesiosis due to Babesia divergens |
| B60.09 | Other babesiosis |
| B60.2 | Naegleriasis |
| B88.09 | Other acariasis |
| B96.83 | Acinetobacter baumannii as the cause of diseases classified elsewhere |
| B97.21 | SARS-associated coronavirus as the cause of diseases classified elsewhere |
| B97.29 | Other coronavirus as the cause of diseases classified elsewhere |
| B97.35 | Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere |
| B99.9 | Unspecified infectious disease |
| C46.0 | Kaposi's sarcoma of skin |
| C46.1 | Kaposi's sarcoma of soft tissue |
| C46.2 | Kaposi's sarcoma of palate |
| C46.3 | Kaposi's sarcoma of lymph nodes |
| C46.4 | Kaposi's sarcoma of gastrointestinal sites |
| C46.50 | Kaposi's sarcoma of unspecified lung |
| C46.51 | Kaposi's sarcoma of right lung |
| C46.52 | Kaposi's sarcoma of left lung |
| C46.7 | Kaposi's sarcoma of other sites |
| D26.0 | Other benign neoplasm of cervix uteri |
| D57.01 | Hb-SS disease with acute chest syndrome |
| D59.30 | Hemolytic-uremic syndrome, unspecified |
| D59.31 | Infection-associated hemolytic-uremic syndrome |
| D61.03 | Fanconi anemia |
| D61.09 | Other constitutional aplastic anemia |
| D61.1 | Drug-induced aplastic anemia |
| D61.2 | Aplastic anemia due to other external agents |
| D61.3 | Idiopathic aplastic anemia |
| D61.810 | Antineoplastic chemotherapy induced pancytopenia |
| D61.811 | Other drug-induced pancytopenia |
| D61.818 | Other pancytopenia |
| D61.82 | Myelophthisis |
| D61.89 | Other specified aplastic anemias and other bone marrow failure syndromes |
| D61.9 | Aplastic anemia, unspecified |
| D64.81 | Anemia due to antineoplastic chemotherapy |
| D64.89 | Other specified anemias |
| D70.0 | Congenital agranulocytosis |
| D70.1 | Agranulocytosis secondary to cancer chemotherapy |
| D70.2 | Other drug-induced agranulocytosis |
| D70.3 | Neutropenia due to infection |
| D70.4 | Cyclic neutropenia |
| D70.9 | Neutropenia, unspecified |
| D71.1 | Leukocyte adhesion deficiency |
| D71.8 | Other functional disorders of polymorphonuclear neutrophils |
| D71.9 | Functional disorders of polymorphonuclear neutrophils, unspecified |
| D80.0 | Hereditary hypogammaglobulinemia |
| D80.1 | Nonfamilial hypogammaglobulinemia |
| D80.2 | Selective deficiency of immunoglobulin A [IgA] |
| D80.3 | Selective deficiency of immunoglobulin G [IgG] subclasses |
| D80.4 | Selective deficiency of immunoglobulin M [IgM] |
| D80.5 | Immunodeficiency with increased immunoglobulin M [IgM] |
| D80.6 | Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia |
| D80.8 | Other immunodeficiencies with predominantly antibody defects |
| D80.9 | Immunodeficiency with predominantly antibody defects, unspecified |
| D81.0 | Severe combined immunodeficiency [SCID] with reticular dysgenesis |
| D81.1 | Severe combined immunodeficiency [SCID] with low T- and B-cell numbers |
| D81.2 | Severe combined immunodeficiency [SCID] with low or normal B-cell numbers |
| D81.30 | Adenosine deaminase deficiency, unspecified |
| D81.31 | Severe combined immunodeficiency due to adenosine deaminase deficiency |
| D81.32 | Adenosine deaminase 2 deficiency |
| D81.39 | Other adenosine deaminase deficiency |
| D81.4 | Nezelof's syndrome |
| D81.5 | Purine nucleoside phosphorylase [PNP] deficiency |
| D81.6 | Major histocompatibility complex class I deficiency |
| D81.7 | Major histocompatibility complex class II deficiency |
| D81.810 | Biotinidase deficiency |
| D81.818 | Other biotin-dependent carboxylase deficiency |
| D81.82 | Activated Phosphoinositide 3-kinase Delta Syndrome [APDS] |
| D81.89 | Other combined immunodeficiencies |
| D81.9 | Combined immunodeficiency, unspecified |
| D82.0 | Wiskott-Aldrich syndrome |
| D82.1 | Di George's syndrome |
| D82.2 | Immunodeficiency with short-limbed stature |
| D82.3 | Immunodeficiency following hereditary defective response to Epstein-Barr virus |
| D82.4 | Hyperimmunoglobulin E [IgE] syndrome |
| D82.8 | Immunodeficiency associated with other specified major defects |
| D83.0 | Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function |
| D83.1 | Common variable immunodeficiency with predominant immunoregulatory T-cell disorders |
| D83.2 | Common variable immunodeficiency with autoantibodies to B- or T-cells |
| D83.8 | Other common variable immunodeficiencies |
| D83.9 | Common variable immunodeficiency, unspecified |
| D84.0 | Lymphocyte function antigen-1 [LFA-1] defect |
| D84.1 | Defects in the complement system |
| D84.821 | Immunodeficiency due to drugs |
| D84.822 | Immunodeficiency due to external causes |
| D84.89 | Other immunodeficiencies |
| D84.9 | Immunodeficiency, unspecified |
| D89.0 | Polyclonal hypergammaglobulinemia |
| D89.1 | Cryoglobulinemia |
| D89.2 | Hypergammaglobulinemia, unspecified |
| D89.3 | Immune reconstitution syndrome |
| D89.41 | Monoclonal mast cell activation syndrome |
| D89.42 | Idiopathic mast cell activation syndrome |
| D89.43 | Secondary mast cell activation |
| D89.44 | Hereditary alpha tryptasemia |
| D89.49 | Other mast cell activation disorder |
| D89.810 | Acute graft-versus-host disease |
| D89.811 | Chronic graft-versus-host disease |
| D89.812 | Acute on chronic graft-versus-host disease |
| D89.813 | Graft-versus-host disease, unspecified |
| D89.82 | Autoimmune lymphoproliferative syndrome [ALPS] |
| D89.89 | Other specified disorders involving the immune mechanism, not elsewhere classified |
| E08.43 | Diabetes mellitus due to underlying condition with diabetic autonomic (poly)neuropathy |
| E08.52 | Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy with gangrene |
| E10.43 | Type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy |
| E10.52 | Type 1 diabetes mellitus with diabetic peripheral angiopathy with gangrene |
| E11.43 | Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy |
| E11.52 | Type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene |
| E13.43 | Other specified diabetes mellitus with diabetic autonomic (poly)neuropathy |
| E84.0 | Cystic fibrosis with pulmonary manifestations |
| E84.19 | Cystic fibrosis with other intestinal manifestations |
| E84.8 | Cystic fibrosis with other manifestations |
| G00.0 | Hemophilus meningitis |
| G00.1 | Pneumococcal meningitis |
| G00.2 | Streptococcal meningitis |
| G00.8 | Other bacterial meningitis |
| G00.9 | Bacterial meningitis, unspecified |
| G03.0 | Nonpyogenic meningitis |
| G03.9 | Meningitis, unspecified |
| G04.01 | Postinfectious acute disseminated encephalitis and encephalomyelitis (postinfectious ADEM) |
| G04.02 | Postimmunization acute disseminated encephalitis, myelitis and encephalomyelitis |
| G04.30 | Acute necrotizing hemorrhagic encephalopathy, unspecified |
| G04.31 | Postinfectious acute necrotizing hemorrhagic encephalopathy |
| G04.32 | Postimmunization acute necrotizing hemorrhagic encephalopathy |
| G04.39 | Other acute necrotizing hemorrhagic encephalopathy |
| G04.81 | Other encephalitis and encephalomyelitis |
| G04.82 | Acute flaccid myelitis |
| G04.89 | Other myelitis |
| G04.90 | Encephalitis and encephalomyelitis, unspecified |
| G04.91 | Myelitis, unspecified |
| G05.3 | Encephalitis and encephalomyelitis in diseases classified elsewhere |
| G05.4 | Myelitis in diseases classified elsewhere |
| I27.0 | Primary pulmonary hypertension |
| I27.21 | Secondary pulmonary arterial hypertension |
| I27.22 | Pulmonary hypertension due to left heart disease |
| I27.23 | Pulmonary hypertension due to lung diseases and hypoxia |
| I27.24 | Chronic thromboembolic pulmonary hypertension |
| I27.29 | Other secondary pulmonary hypertension |
| I27.81 | Cor pulmonale (chronic) |
| I27.82 | Chronic pulmonary embolism |
| I27.83 | Eisenmenger's syndrome |
| I27.89 | Other specified pulmonary heart diseases |
| I33.0 | Acute and subacute infective endocarditis |
| I50.21 | Acute systolic (congestive) heart failure |
| I50.22 | Chronic systolic (congestive) heart failure |
| I50.23 | Acute on chronic systolic (congestive) heart failure |
| I50.31 | Acute diastolic (congestive) heart failure |
| I50.32 | Chronic diastolic (congestive) heart failure |
| I50.33 | Acute on chronic diastolic (congestive) heart failure |
| I50.41 | Acute combined systolic (congestive) and diastolic (congestive) heart failure |
| I50.42 | Chronic combined systolic (congestive) and diastolic (congestive) heart failure |
| I50.43 | Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure |
| I50.811 | Acute right heart failure |
| I50.812 | Chronic right heart failure |
| I50.813 | Acute on chronic right heart failure |
| I50.814 | Right heart failure due to left heart failure |
| I50.82 | Biventricular heart failure |
| I50.83 | High output heart failure |
| I50.84 | End stage heart failure |
| I50.89 | Other heart failure |
| J00 | Acute nasopharyngitis [common cold] |
| J02.9 | Acute pharyngitis, unspecified |
| J04.0 | Acute laryngitis |
| J04.10 | Acute tracheitis without obstruction |
| J04.11 | Acute tracheitis with obstruction |
| J04.2 | Acute laryngotracheitis |
| J04.30 | Supraglottitis, unspecified, without obstruction |
| J04.31 | Supraglottitis, unspecified, with obstruction |
| J05.0 | Acute obstructive laryngitis [croup] |
| J05.10 | Acute epiglottitis without obstruction |
| J05.11 | Acute epiglottitis with obstruction |
| J06.0 | Acute laryngopharyngitis |
| J06.9 | Acute upper respiratory infection, unspecified |
| J09.X1 | Influenza due to identified novel influenza A virus with pneumonia |
| J09.X2 | Influenza due to identified novel influenza A virus with other respiratory manifestations |
| J09.X3 | Influenza due to identified novel influenza A virus with gastrointestinal manifestations |
| J09.X9 | Influenza due to identified novel influenza A virus with other manifestations |
| J10.01 | Influenza due to other identified influenza virus with the same other identified influenza virus pneumonia |
| J10.08 | Influenza due to other identified influenza virus with other specified pneumonia |
| J10.1 | Influenza due to other identified influenza virus with other respiratory manifestations |
| J10.2 | Influenza due to other identified influenza virus with gastrointestinal manifestations |
| J10.81 | Influenza due to other identified influenza virus with encephalopathy |
| J10.82 | Influenza due to other identified influenza virus with myocarditis |
| J10.83 | Influenza due to other identified influenza virus with otitis media |
| J10.89 | Influenza due to other identified influenza virus with other manifestations |
| J11.08 | Influenza due to unidentified influenza virus with specified pneumonia |
| J11.1 | Influenza due to unidentified influenza virus with other respiratory manifestations |
| J11.2 | Influenza due to unidentified influenza virus with gastrointestinal manifestations |
| J11.81 | Influenza due to unidentified influenza virus with encephalopathy |
| J11.82 | Influenza due to unidentified influenza virus with myocarditis |
| J11.83 | Influenza due to unidentified influenza virus with otitis media |
| J11.89 | Influenza due to unidentified influenza virus with other manifestations |
| J12.0 | Adenoviral pneumonia |
| J12.1 | Respiratory syncytial virus pneumonia |
| J12.2 | Parainfluenza virus pneumonia |
| J12.3 | Human metapneumovirus pneumonia |
| J12.81 | Pneumonia due to SARS-associated coronavirus |
| J12.82 | Pneumonia due to coronavirus disease 2019 |
| J12.89 | Other viral pneumonia |
| J12.9 | Viral pneumonia, unspecified |
| J13 | Pneumonia due to Streptococcus pneumoniae |
| J15.0 | Pneumonia due to Klebsiella pneumoniae |
| J15.1 | Pneumonia due to Pseudomonas |
| J15.20 | Pneumonia due to staphylococcus, unspecified |
Showing the first 400 of 947 covered codes — this procedure has a large covered-diagnosis set; see the governing LCD/article for the complete list.
Frequently asked questions
Which ICD-10 codes support medical necessity for CPT 0115U?
Medicare coverage policies (LCDs/NCDs and Billing & Coding articles) list 947 ICD-10 diagnosis codes that support medical necessity for CPT 0115U. The covered codes are listed on this page. Coverage varies by MAC/state — always confirm against the policy that applies to you.
What is a medical-necessity (LCD/NCD) crosswalk?
A claim whose procedure isn't supported by a covered diagnosis denies as "not medically necessary" (CARC 50). CMS coverage policies define which diagnoses justify a procedure; this page is the ICD-10 → CPT 0115U view of that relationship.
Catch medical-necessity denials before you bill. CareNiva scrubs claims against LCD/NCD coverage and flags unsupported diagnoses — in the same platform you run visits and billing.
More free billing tools: all crosswalks · NCCI edits · Medicare fees · denial codes
Informational only, not coding, billing, or legal advice. Based on CMS Medicare Coverage Database data; verify the current LCD/NCD for your MAC before billing.
Bill it right the first time
Join providers across the country delivering modern virtual care with CareNiva. Free to start, ready in minutes.
100% Satisfaction Guaranteed — try it risk-free